
The growing issue of antibiotic resistance is finding itself increasingly central in pharma’s priorities, though many still argue that the …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

